106 related articles for article (PubMed ID: 16019559)
41. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
Duprez E; Lillehaug JR; Naoe T; Lanotte M
Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
[TBL] [Abstract][Full Text] [Related]
42. A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report.
Grassilli S; Nika E; Lambertini E; Brugnoli F; Piva R; Capitani S; Bertagnolo V
Cell Oncol (Dordr); 2016 Oct; 39(5):483-489. PubMed ID: 27480083
[TBL] [Abstract][Full Text] [Related]
43. [Transcriptional regulation of BHLHB2 induced by PML-RARα].
Jia XH; Yang WT; Zhu XH; Yang XW; Zhang J; Wang KK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1005-9. PubMed ID: 21867633
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of poly(ADP-ribose) polymerase promotes cell cycle arrest and inhibits neutrophilic differentiation of NB4 acute promyelocytic leukemia cells.
Bhatia M; Kirkland JB; Meckling-Gill KA
Cell Growth Differ; 1996 Jan; 7(1):91-100. PubMed ID: 8788037
[TBL] [Abstract][Full Text] [Related]
45. Modulation of homeobox B6 and B9 genes expression in human leukemia cell lines during myelomonocytic differentiation.
Ohnishi K; Tobita T; Sinjo K; Takeshita A; Ohno R
Leuk Lymphoma; 1998 Nov; 31(5-6):599-608. PubMed ID: 9922051
[TBL] [Abstract][Full Text] [Related]
46. [Effect of antisense oligodeoxynucleotide (ASODN) to PML-RAR alpha fusion gene on acute promyelocytic leukemia cell line NB4].
Yu W; Sun B; Chen Z
Zhonghua Xue Ye Xue Za Zhi; 1998 May; 19(5):227-30. PubMed ID: 11243116
[TBL] [Abstract][Full Text] [Related]
47. Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.
Huang D; Yang Y; Sun J; Dong X; Wang J; Liu H; Lu C; Chen X; Shao J; Yan J
Front Med; 2017 Sep; 11(3):410-422. PubMed ID: 28687976
[TBL] [Abstract][Full Text] [Related]
48. The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.
Jing Y
Leuk Lymphoma; 2004 Apr; 45(4):639-48. PubMed ID: 15160934
[TBL] [Abstract][Full Text] [Related]
49. NLS-RARα Inhibits the Effects of All-trans Retinoic Acid on NB4 Cells by Interacting with P38α MAPK.
Xiao C; Zhong L; Shan Z; Xu T; Gan L; Song H; Yang R; Li L; Liu B
Int J Med Sci; 2016; 13(8):611-9. PubMed ID: 27499693
[TBL] [Abstract][Full Text] [Related]
50. Acute promyelocytic leukaemia cells resistant to retinoic acid show further perturbation of the RAR alpha signal transduction system.
Dermime S; Grignani F; Rogaia D; Liberatore C; Marchesi E; Gambacorti-Passerini C
Leuk Lymphoma; 1995 Jan; 16(3-4):289-95. PubMed ID: 7719237
[TBL] [Abstract][Full Text] [Related]
51. Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression.
Xu K; Guidez F; Glasow A; Chung D; Petrie K; Stegmaier K; Wang KK; Zhang J; Jing Y; Zelent A; Waxman S
Cancer Res; 2005 Sep; 65(17):7856-65. PubMed ID: 16140955
[TBL] [Abstract][Full Text] [Related]
52. Targeting the PML/RAR alpha translocation product triggers apoptosis in promyelocytic leukemia cells.
Nason-Burchenal K; Takle G; Pace U; Flynn S; Allopenna J; Martin P; George ST; Goldberg AR; Dmitrovsky E
Oncogene; 1998 Oct; 17(14):1759-68. PubMed ID: 9778041
[TBL] [Abstract][Full Text] [Related]
53. Bone morphogenetic proteins regulate differentiation of human promyelocytic leukemia cells.
Topić I; Ikić M; Ivčević S; Kovačić N; Marušić A; Kušec R; Grčević D
Leuk Res; 2013 Jun; 37(6):705-12. PubMed ID: 23528261
[TBL] [Abstract][Full Text] [Related]
54. Over-expression of Mcl-1 impairs the ability of ATRA to induce growth arrest and differentiation in acute promyelocytic leukemia cells.
Yang J; Ikezoe T; Nishioka C; Yokoyama A
Apoptosis; 2013 Nov; 18(11):1403-1415. PubMed ID: 23760752
[TBL] [Abstract][Full Text] [Related]
55. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
[TBL] [Abstract][Full Text] [Related]
56. [Effects of interferon regulatory factor 9 on the biological phenotypes in PML-RARα-induced promyelocytic leukemia].
Yang X; Xing HY; Tang KJ; Tian Z; Rao Q; Wang M; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2022 May; 43(5):370-375. PubMed ID: 35680593
[No Abstract] [Full Text] [Related]
57. PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors.
Minucci S; Monestiroli S; Giavara S; Ronzoni S; Marchesi F; Insinga A; Diverio D; Gasparini P; Capillo M; Colombo E; Matteucci C; Contegno F; Lo-Coco F; Scanziani E; Gobbi A; Pelicci PG
Blood; 2002 Oct; 100(8):2989-95. PubMed ID: 12351412
[TBL] [Abstract][Full Text] [Related]
58. Alteration in the cellular response to retinoic acid of a human acute promyelocytic leukemia cell line, UF-1, carrying a patient-derived mutant PML-RARalpha chimeric gene.
Sato A; Imaizumi M; Hoshi Y; Rikiishi T; Fujii K; Kizaki M; Kagechika H; Kakizuka A; Hayashi Y; Iinuma K
Leuk Res; 2004 Sep; 28(9):959-67. PubMed ID: 15234573
[TBL] [Abstract][Full Text] [Related]
59. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
60. Acute promyelocytic leukemia: a paradigm for differentiation therapy.
Grimwade D; Mistry AR; Solomon E; Guidez F
Cancer Treat Res; 2010; 145():219-35. PubMed ID: 20306254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
